Richard J. Solove articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2015/07/01 12:08
2015/07/01 12:08
1h
Nanoparticles packed with a clinically used chemotherapy drug and coated with an oligosaccharide derived from the carapace of crustaceans might effectively target and kill cancer stem-like cells,...
2015/07/01 12:08
2015/07/01 12:08
Latest videos
2015/06/04 05:08
2015/06/04 05:08
27d
New findings suggest that a gene called IDH1 might be prognostic marker for a rare form of brain cancer. Patients in this study who had a mutated IDH gene lived an average of 7.9 years after diagnosis...
2015/06/01 09:17
2015/06/01 09:17
30d
CHICAGO, Illinois (USA)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) hat heute Ergebnisse der Phase-3-Studie 119 vorgestellt, in der Zydelig® (Idelalisib) in Verbindung mit Ofatumumab bei...
2015/05/31 23:17
2015/05/31 23:17
30d
CHICAGO--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) ha annunciato oggi i risultati derivati da una sperimentazione clinica di Fase 3, lo Studio 119, sull'uso sperimentale di Zydelig®...
2015/05/31 23:17
2015/05/31 23:17
30d
CHICAGO--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) a annoncé aujourd'hui les résultats de l'Étude clinique 119 de phase 3 relative à l'utilisation expérimentale de Zydelig® (idélalisib) en...
2015/05/31 13:17
2015/05/31 13:17
1m
CHICAGO--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced results from the Phase 3 clinical Study 119 of an investigational use of Zydelig® (idelalisib) in combination with...
2015/07/01 12:08
2015/07/01 12:08
Latest from Twitter